Published :
Report ID:
Pages :
Format :
The Global Medical Elastomer Market Size accounted for USD 8.4 Billion in 2023 and is estimated to achieve a market size of USD 19.2 Billion by 2032 growing at a CAGR of 9.7% from 2024 to 2032.
Medical elastomers are flexible, durable materials used in medical devices that require biocompatibility and the ability to withstand sterilization processes. They are often made from silicone, thermoplastic elastomers, or thermoset rubbers, providing critical properties like flexibility, strength, and chemical resistance. These materials are essential in applications such as medical tubing, seals, and gaskets, where performance and safety are paramount.
Frontiers Organizations states that an innovative elastomer with outstanding shape memory and self-healing properties offers a strong foundation and promising potential for creating self-contracting intelligent surgical sutures in the biomedical field. Overall, their importance lies in ensuring the reliability and longevity of medical devices while maintaining safety standards for patient care.
Market |
Medical Elastomer Market |
Medical Elastomer Market Size 2023 |
USD 8.4 Billion |
Medical Elastomer Market Forecast 2032 |
USD 19.2 Billion |
Medical Elastomer Market CAGR During 2024 - 2032 |
9.7% |
Medical Elastomer Market Analysis Period |
2020 - 2032 |
Medical Elastomer Market Base Year |
2023 |
Medical Elastomer Market Forecast Data |
2024 - 2032 |
Segments Covered |
By Type, By End-User, and By Geography |
Regional Scope |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
The Hygenic Corporation, RTP Company, Kuraray Co., Ltd., Biomerics, Dow, BASF SE, Trelleborg AB, Momentive Performance Materials Inc., Kraton Corporation, Polyone Corporation, Foster Corporation, HEXPOL AB, Celanese Corporation, RAUMEDIC AG, DSM, DuPont, and Teknor Apex. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
The increasing preference for minimally invasive surgeries is driving the demand for medical elastomers, as these materials offer flexibility, durability, and biocompatibility. Elastomers are crucial in devices like catheters and stents, which are used in minimally invasive procedures. As the trend toward less invasive treatments grows, the need for high-performance elastomers rises.
Medical devices such as infusion pumps, prosthetics, and diagnostic equipment require materials that are both flexible and durable. Elastomers meet these needs by providing strength, flexibility, and the ability to withstand repeated use. For instance, as per India Brand Equity Foundation, on April 26, 2023, the Union Cabinet approved the National Medical Devices Policy, 2023. This policy is designed to support the structured growth of the medical device sector, aiming to enhance public health outcomes through improved access, affordability, quality, and innovation. It is projected that the policy will help the medical devices sector expand from its current value of US$ 11 billion to US$ 50 billion by 2030. The growing reliance on such devices, especially in chronic care and rehabilitation, further fuels the demand for medical elastomers.
The production of specialized medical elastomers, especially those with biocompatible or high-performance properties, can be costly. The need for strict quality control and regulatory compliance increases manufacturing expenses. These high costs can limit the affordability and accessibility of elastomer-based medical devices, hindering market growth.
In November 2024, Teknor Apex, a trusted supplier of specialized plastic compounds for the healthcare sector, will introduce new grades of medical-grade thermoplastic elastomer (TPE) specifically designed for biopharmaceutical tube applications. This specialization in medical elastomers is expected to become opportunity in medical elastomer market, expanding its reach and increasing demand for advanced healthcare solutions.
The worldwide market for medical elastomer is split based on type, end-user, and geography.
· Thermoplastic Elastomer
· Thermoset Elastomer
According to the medical elastomer industry analysis, the thermoplastic elastomer (TPE) segment leads due to its unique combination of thermoplastic processing and elastomeric properties. TPEs are highly versatile, offering flexibility, durability, and ease of molding, which makes them ideal for a wide range of medical applications. Their ability to be recycled and processed at lower costs compared to other elastomers also drives their adoption in cost-sensitive markets. As the demand for lightweight, biocompatible materials rises, TPEs are becoming increasingly popular in medical device manufacturing.
· Implants
· Syringes
· Gloves
· Catheters
· Medical Bags
· Medical Tubes
· Others
According to the medical elastomer market forecast, the medical tubes segment is dominating due to their essential role in various healthcare applications, including intravenous (IV) administration, catheterization, and respiratory devices. Elastomers provide the necessary flexibility, biocompatibility, and resistance to sterilization methods, making them ideal for medical tubes. The increasing prevalence of chronic diseases and the demand for minimally invasive treatments contribute to the growing need for medical tubing. Additionally, advancements in elastomer technology are enhancing the performance and safety of medical tubes, further driving market expansion.
North America
· U.S.
· Canada
Europe
· U.K.
· Germany
· France
· Spain
· Rest of Europe
Asia-Pacific
· India
· Japan
· China
· Australia
· South Korea
· Rest of Asia-Pacific
Latin America
· Brazil
· Mexico
· Rest of LATAM
The Middle East & Africa
· South Africa
· GCC Countries
· Rest of the Middle East & Africa (ME&A)
For several reasons, North America leads the medical elastomer market due to its advanced healthcare infrastructure, high demand for medical devices, and strong regulatory frameworks. The U.S. is a major hub for medical device manufacturers, driving the need for high-quality elastomers in various applications. For instance, in October 2021, DuPont inaugurated its new medical elastomers mixers at the Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan, in Unites States with a formal ribbon-cutting ceremony. The acquisition of these mixers is a strategic response to the increasing demand for products from DuPont Liveo Healthcare Solutions' clients. Additionally, continuous technological advancements and a well-established healthcare system contribute to North America's dominance in the market.
Asia-Pacific is the fastest-growing region in the medical elastomer market, driven by expanding healthcare access, rising patient populations, and rapid industrialization. Countries like China and India are increasingly investing in healthcare infrastructure, creating significant demand for medical elastomers in devices such as catheters, tubes, and surgical implants. For instance, India Investment Grid states that India aims to become a global healthcare hub by 2023, with a target to allocate 2.5% of its GDP towards public health expenditure. This evolving scenario creates significant investment opportunities in the country's medical infrastructure. The region's growing manufacturing capabilities and cost-effective production are further fueling market growth.
Some of the top medical elastomer companies offered in our report include The Hygenic Corporation, RTP Company, Kuraray Co., Ltd., Biomerics, Dow, BASF SE, Trelleborg AB, Momentive Performance Materials Inc., Kraton Corporation, Polyone Corporation, Foster Corporation, HEXPOL AB, Celanese Corporation, RAUMEDIC AG, DSM, DuPont, and Teknor Apex.
The medical elastomer market size was valued at USD 8.4 Billion in 2023.
The CAGR of medical elastomer is 9.7% during the analysis period of 2024 to 2032.
The key players operating in the global market are including The Hygenic Corporation, RTP Company, Kuraray Co., Ltd., Biomerics, Dow, BASF SE, Trelleborg AB, Momentive Performance Materials Inc., Kraton Corporation, Polyone Corporation, Foster Corporation, HEXPOL AB, Celanese Corporation, RAUMEDIC AG, DSM, DuPont, and Teknor Apex.
North America held the dominating position in medical elastomer industry during the analysis period of 2024 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of medical elastomer during the analysis period of 2024 to 2032.
The current trends and dynamics in the medical elastomer industry include growing demand for minimally invasive surgeries, increasing use of medical devices requiring flexible, durable materials, and advancements in biocompatible materials for patient safety
The thermoplastic elastomer expected to hold the maximum share of the medical elastomer industry.